← Leaderboards
Weston W Blakeslee
Rxrevu, Inc.
$374,161
Attributed
$374,161
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$374,161 · 2
By mechanism
R43$374,161 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Pharmacotherapy”
- Jeffrey Reich · Sparian Biosciences, Inc.$15,164,944
- Joshua K Lin · Brigham And Women'S Hospital$10,894,731
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- Richard Scranton · Lyndra Therapeutics, Inc.$9,277,094
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
- Miriam Komaromy · Rand Corporation$7,501,695
Research focus
PharmacotherapyPhysiciansEvidence BasePharmaceutical PreparationsSmall Business Innovation Research GrantTechnologyElectronic Health RecordEnvironmentHealthcarePatient-Focused OutcomesProviderRecommendationSupport ToolsSurfaceDesignClinical ProtocolsBaseEnsureAdoptionFatigueHealthcare SystemsModernizationClinical Decision Support SystemsClinic